tradingkey.logo

Inspire Veterinary Partners Inc

IVP
0.038USD
-0.003-6.68%
收盘 12/24, 13:00美东报价延迟15分钟
249.95K总市值
亏损市盈率 TTM

Inspire Veterinary Partners Inc

0.038
-0.003-6.68%

关于 Inspire Veterinary Partners Inc 公司

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general practice hospitals which serve all types of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals, consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and other health and wellness offerings.

Inspire Veterinary Partners Inc简介

公司代码IVP
公司名称Inspire Veterinary Partners Inc
上市日期Aug 30, 2023
CEOCarr (Kimball)
员工数量113
证券类型Ordinary Share
年结日Aug 30
公司地址780 Lynnhaven Pkwy #400
城市VIRGINIA BEACH
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编23452
电话17572883088
网址https://www.inspirevet.com/
公司代码IVP
上市日期Aug 30, 2023
CEOCarr (Kimball)

Inspire Veterinary Partners Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Lynley Kees
Ms. Lynley Kees
Vice President of Human Resources
Vice President of Human Resources
--
--
Mr. Kevin M. Mcgrath
Mr. Kevin M. Mcgrath
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--
Mr. Larry Alexander
Mr. Larry Alexander
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月18日 周二
更新时间: 11月18日 周二
持股股东
股东类型
持股股东
持股股东
占比
DRW Securities, LLC
0.25%
Geode Capital Management, L.L.C.
0.03%
Citi Investment Research (US)
0.01%
其他
99.71%
持股股东
持股股东
占比
DRW Securities, LLC
0.25%
Geode Capital Management, L.L.C.
0.03%
Citi Investment Research (US)
0.01%
其他
99.71%
股东类型
持股股东
占比
Investment Advisor
0.25%
Investment Advisor/Hedge Fund
0.03%
Research Firm
0.01%
其他
99.71%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
30
85.70K
2.35%
-162.35K
2025Q2
36
227.92K
10.75%
+186.48K
2025Q1
37
233.23K
11.15%
+199.50K
2024Q4
35
26.63K
1.96%
+14.11K
2024Q3
29
12.19K
10.24%
+9.83K
2024Q2
26
1.53K
5.46%
+829.00
2024Q1
24
680.00
3.62%
+167.00
2023Q4
22
514.00
27.03%
+264.00
2023Q3
15
280.00
16.84%
+280.00

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Geode Capital Management, L.L.C.
10.62K
0.29%
+580.00
+5.78%
Jun 30, 2025
Tower Research Capital LLC
2.72K
0.08%
+554.00
+25.58%
Jun 30, 2025
UBS Financial Services, Inc.
12.15K
0.34%
+200.00
+1.67%
Jun 30, 2025
Osaic Holdings, Inc.
84.00
0%
-76.00
-47.50%
Jun 30, 2025
Harbour Investments, Inc
54.00
0%
--
--
Jun 30, 2025
MAI Capital Management, LLC
39.00
0%
--
--
Jun 30, 2025
BofA Global Research (US)
19.00
0%
+8.00
+72.73%
Jun 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
公告日期
类型
比率
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1

常见问题

Inspire Veterinary Partners Inc的前五大股东是谁?

Inspire Veterinary Partners Inc 的前五大股东如下:
Geode Capital Management, L.L.C.持有股份:10.62K,占总股份比例:0.29%。
Tower Research Capital LLC持有股份:2.72K,占总股份比例:0.08%。
UBS Financial Services, Inc.持有股份:12.15K,占总股份比例:0.34%。
Osaic Holdings, Inc.持有股份:84.00,占总股份比例:0.00%。
Harbour Investments, Inc持有股份:54.00,占总股份比例:0.00%。

Inspire Veterinary Partners Inc的前三大股东类型是什么?

Inspire Veterinary Partners Inc 的前三大股东类型分别是:
DRW Securities, LLC
Geode Capital Management, L.L.C.
Citi Investment Research (US)

有多少机构持有Inspire Veterinary Partners Inc(IVP)的股份?

截至2025Q3,共有30家机构持有Inspire Veterinary Partners Inc的股份,合计持有的股份价值约为85.70K,占公司总股份的2.35%。与2025Q2相比,机构持股有所增加,增幅为-8.40%。

哪个业务部门对Inspire Veterinary Partners Inc的收入贡献最大?

在--,--业务部门对Inspire Veterinary Partners Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI